OQROGet OQRO Pro
Insider trade

Boston Scientific (BSX)Director sold ~$424K

Edward J Ludwig, Director at Boston Scientific, sold ~$424K of Boston Scientific shares.

~$424K
Approx. value · 4,000 sh @ $106.03
18K
Holds after · shares reported
Traded
Jul 25, 2025
Filed
Jul 28, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 29, 2024CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  2. Dec 11, 2024CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  3. May 12, 2025CongressDisclosed sale of BSX — reported range $15,001 - $50,000
  4. May 13, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  5. May 29, 2025InsiderDirector sold ~$418K of BSX shares in the open market
  6. Jun 2, 2025Insider · 1 personInsiders: 2 sales (~$17.1M)
  7. Jun 4, 2025InsiderOfficer sold ~$5.8M of BSX shares in the open market
  8. Jun 11, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  9. Jun 26, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  10. Jul 1, 2025InsiderOfficer sold ~$5.35M of BSX shares in the open market
  11. Jul 25, 2025 · this disclosureInsiderDirector sold ~$424K of BSX shares in the open market

What came next

  1. Jul 29, 2025InsiderDirector sold ~$310K of BSX shares in the open market
  2. Jul 31, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  3. Aug 1, 2025Insider · 2 peopleInsiders: 2 sales (~$7.0M)
  4. Aug 4, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  5. Aug 28, 2025FDARecall: Extractor Pro RX Retrieval Balloon Catheter; UPN (REF): (1) M00547030 (9-12mm Below), (2) M00547000 (9-12mm Above);
  6. Sep 2, 2025Insider · 1 personInsiders: 2 sales (~$5.3M)
  7. Sep 11, 2025FDARecall: TENACIO Pump without InhibiZone; UPN: 72404420;
  8. Sep 11, 2025FDARecall: TENACIO Pump with InhibiZone; UPN: 72404429;
  9. Sep 11, 2025FDARecall: LGX Preconnect with TENACIO Pump without InhibiZone; UPNs: (1) 72404405 (12CM IP), (2) 72404407 (18CM IP);
  10. Sep 11, 2025FDARecall: CXR Preconnect with TENACIO Pump with InhibiZone; UPNs: (1) UPN: 72404461 (12CM PS IZ), (2) 72404462 (14CM PS IZ), (3) 72404463 (16CM PS IZ), (4) 72404464 (18C…
  11. Sep 11, 2025FDARecall: CX Preconnect with TENACIO Pump without InhibiZone; UPNs: (1) 72404486 (15CM IP), (2) 72404488 (21CM IP);
  12. Sep 11, 2025FDARecall: LGX Preconnect with TENACIO Pump with InhibiZone; UPNs: (1) UPN: 72404450 (12CM PS IZ), (2) 72404451 (15CM PS IZ), (3) 72404452 (18CM PS IZ), (4) 72404453 (21C…
  13. Sep 11, 2025FDARecall: CX Preconnect with TENACIO Pump with InhibiZone; UPNs: (1) UPN: 72404430 (12CM PS IZ), (2) 72404431 (15CM PS IZ), (3) 72404432 (18CM PS IZ), (4) 72404433 (21CM…
  14. Sep 12, 2025FDAFDA device clearance: LUX-Dx II Insertable Cardiac Monitor (M302); LUX-Dx II+ Insertable Cardiac Monitor (M312)
  15. Sep 23, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
  16. Sep 24, 2025FDAFDA device clearance: LithoVue Elite Single-Use Digital Flexible Ureteroscope - Standard with pressure monitoring (M0067940000); LithoVue Elite Single-Use Digital Flexible Ureterosc…
  17. Sep 26, 2025FDAFDA device clearance: Radial Jaw 4 Pulmonary Biopsy Forceps
  18. Oct 9, 2025FDAFDA device clearance: Orca Air/Water and Suction Valves
  19. Oct 17, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  20. Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports, 64 fund holdings reports (13F) and 8 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Edward J Ludwig, Director

The full history of Edward J Ludwig, Director is on the profile page.

How this filing works

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data